The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
BZQ | CURE | BZQ / CURE | |
Gain YTD | -38.201 | -12.347 | 309% |
Net Assets | 7.05M | 165M | 4% |
Total Expense Ratio | 0.95 | 0.93 | 102% |
Turnover | N/A | 23.00 | - |
Yield | 6.04 | 1.40 | 433% |
Fund Existence | 16 years | 14 years | - |
BZQ | CURE | |
---|---|---|
RSI ODDS (%) | 2 days ago89% | N/A |
Stochastic ODDS (%) | 2 days ago90% | 2 days ago87% |
Momentum ODDS (%) | 2 days ago90% | 2 days ago82% |
MACD ODDS (%) | 2 days ago90% | 2 days ago84% |
TrendWeek ODDS (%) | 2 days ago90% | 2 days ago90% |
TrendMonth ODDS (%) | 2 days ago90% | 2 days ago90% |
Advances ODDS (%) | 11 days ago90% | 2 days ago90% |
Declines ODDS (%) | 9 days ago90% | 7 days ago90% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago90% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago90% |
A.I.dvisor indicates that over the last year, CURE has been closely correlated with IQV. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then IQV could also see price increases.
Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
---|---|---|---|---|
CURE | 100% | +5.99% | ||
IQV - CURE | 68% Closely correlated | +3.66% | ||
GEHC - CURE | 64% Loosely correlated | +0.99% | ||
TMO - CURE | 61% Loosely correlated | +9.14% | ||
REGN - CURE | 58% Loosely correlated | +2.04% | ||
IDXX - CURE | 57% Loosely correlated | +1.63% | ||
More |